biosimilars

Teva and mAbxience partner to develop biosimilar candidate for oncology
Pharmaceutical Technology
Fri, 10/4/24 - 09:28 am
Teva Pharmaceutical
mAbxience
oncology
biosimilars
Regeneron's stock drops as it loses bid to block Amgen's Eylea biosimilar
Fierce Pharma
Tue, 09/24/24 - 11:56 am
Regeneron
Amgen
legal
biosimilars
Eylea
UnitedHealth to remove AbbVie's Humira from some US drug reimbursement lists next year
AOL
Tue, 09/10/24 - 04:33 pm
AbbVie
Humira
biosimilars
Unitedhealth Group
OptumRx
Evernorth Will Offer a Private-Label Stelara Biosimilar in 2025
Managed Healthcare Executive
Thu, 09/5/24 - 10:32 pm
Evernorth Health
Stelara
biosimilars
Janssen
JNJ
IRA biosimilar measure intended to boost uptake so far has 'limited' impact: report
Fierce Pharma
Fri, 08/30/24 - 11:25 am
Inflation Reduction Act
Medicare
drug pricing
biosimilars
Patent thickets in federal government’s crosshairs as election 2024 looms
BioSpace
Wed, 08/28/24 - 11:57 am
patents
patent thickets
FTC
PTO
generics
biosimilars
2024 Presidential election
Cigna to remove AbbVie's Humira from some drug reimbursement lists next year
Reuters
Mon, 08/26/24 - 10:14 pm
AbbVie
Humira
biosimilars
Cigna
reimbursement
GlycoNex reports positive results for denosumab biosimilar Phase I trial
Clinical Trials Arena
Tue, 08/20/24 - 10:31 am
GlycoNex
clinical trials
biosimilars
denosumab
osteoporosis
Amgen sues Samsung biotech unit over bone drug copies
Reuters
Tue, 08/13/24 - 11:08 pm
Amgen
Samsung
biologics
biosimilars
legal
Prolia
Xgeva
Sandoz lifts guidance after Humira biosimilar drives another quarter of sales growth
Fierce Pharma
Fri, 08/9/24 - 11:25 am
Sandoz
earnings
biosimilars
Humira
AbbVie
Novartis
GoodRx teams with Boehringer on Humira biosimilar
Axios
Thu, 07/18/24 - 11:21 am
GoodRx
Boehringer Ingelheim
biosimilars
Humira
AbbVie’s Humira continues to lose market share as biosimilars gain ground
BioSpace
Fri, 07/12/24 - 11:35 am
AbbVie
Humira
biosimilars
What Does Wegovy’s Launch in China Mean as Biosimilar Competition Emerges?
BioSpace
Tue, 07/9/24 - 09:19 pm
Wegovy
Novo Nordisk
China
biosimilars
Samsung Bioepis Gets FDA Approval for Biosimilar of J&J’s Stelara
BioSpace
Mon, 07/1/24 - 09:58 pm
Samsung Bioepis
FDA
Pyzchiva
biosimilars
JNJ
Stelara
AbbVie's tight grip on Humira market raises concerns about biosimilars
Reuters
Fri, 06/7/24 - 11:32 am
AbbVie
Humira
biosimilars
FDA approves Amgen's biosimilar to AstraZeneca's rare blood disorder treatment
Reuters
Tue, 05/28/24 - 10:29 pm
Amgen
AstraZeneca
biosimilars
Soliris
Bkemv
FDA approves two biosimilars to blockbuster eye drug Eylea
Reuters
Mon, 05/20/24 - 11:23 am
Regeneron
Eylea
FDA
biosimilars
Biocon Biologics
Yesafli
Opuviz
Samsung BioLogics
Biogen
Biosimilars are gaining ground. The IRA could push them even further next year.
Pharma Voice
Mon, 05/13/24 - 11:21 am
biosimilars
Inflation Reduction Act
drug pricing
Teva Pharm to launch Humira biosimilar as Q1 profit misses estimates
Reuters
Wed, 05/8/24 - 10:58 pm
Teva Pharmaceutical
earnings
biosimilars
AbbVie
Humira
Sandoz delivers 6% sales growth with Humira biosimilar leading the charge
Fierce Pharma
Tue, 05/7/24 - 06:30 pm
Sandoz
earnings
biosimilars
AbbVie
Humira

Pages